Mingfei Yan, MD, PhD

MoFitt
Tampa, United States

Disclosure information not submitted.

Presentation(s):

• SAT-301 - CAMKK2-Regulated Insulin Signaling as A Therapeutic Target for the Treatment of Prostate Cancer and Its Metabolic Comorbidities.

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT